المؤلفون: Turner JA; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Van Gulick RJ; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Robinson WA; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Mughal T; Division of Hematology-Oncology, Tufts University Cancer Center, Boston, Massachusetts, USA., Tobin RP; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., MacBeth ML; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Holman B; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Classon A; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Bagby SM; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Yacob BW; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Hartman SJ; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Silverman I; Ignyta, Inc., San Diego, California, USA., Vorwald VM; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Gorden N; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Gonzalez R; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Gay LM; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Ali SM; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Benson A; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Miller VA; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Ross JS; Foundation Medicine Inc., Cambridge, Massachusetts, USA.; Department of Pathology, Upstate Medical University, Syracuse, New York, USA., Pitts TM; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Rioth MJ; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Lewis KD; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Medina T; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., McCarter MD; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Gonzalez R; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Couts KL; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

المصدر: International journal of cancer [Int J Cancer] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

المؤلفون: Mukherjee N; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA., Katsnelson E; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA., Brunetti TM; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Michel K; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA., Couts KL; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA., Lambert KA; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA., Robinson WA; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Medical Oncology, Aurora, CO, 80045, USA., McCarter MD; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA., Norris DA; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA.; Department of Veterans Affairs Medical Center, Dermatology Section, Denver, CO, 80220, USA., Tobin RP; University of Colorado Anschutz Medical Campus, School of Medicine, Division of Surgical Oncology, Aurora, CO, 80045, USA. Richard.Tobin@cuanschutz.edu., Shellman YG; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Dermatology, Aurora, CO, 80045, USA. Yiqun.shellman@CUAnschutz.edu.; University of Colorado Anschutz Medical Campus, Gates Center for Regenerative Medicine, Aurora, CO, 80045, USA. Yiqun.shellman@CUAnschutz.edu.

المصدر: Cell death & disease [Cell Death Dis] 2024 Mar 08; Vol. 15 (3), pp. 198. Date of Electronic Publication: 2024 Mar 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Skin Neoplasms* , Antineoplastic Agents*/pharmacology , Myeloid-Derived Suppressor Cells*/metabolism, Humans ; Animals ; Mice ; Immune Checkpoint Inhibitors/pharmacology ; Myeloid Cell Leukemia Sequence 1 Protein/metabolism ; CD8-Positive T-Lymphocytes/metabolism

المؤلفون: Katsnelson EN; Department of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, 12800 E 19th Ave, Aurora, CO 80045, United States., Spengler A; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E 19th Ave, Aurora, CO 80045, United States., Domenico J; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E 19th Ave, Aurora, CO 80045, United States., Couts KL; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, 12800 E 19th Ave, Aurora, CO 80045, United States., Loh L; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E 19th Ave, Aurora, CO 80045, United States., Gapin L; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 E 19th Ave, Aurora, CO 80045, United States., McCarter MD; Department of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, 12800 E 19th Ave, Aurora, CO 80045, United States., Tobin RP; Department of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, 12800 E 19th Ave, Aurora, CO 80045, United States.

المصدر: Journal of leukocyte biology [J Leukoc Biol] 2024 Jan 05; Vol. 115 (1), pp. 36-46.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print Cited Medium: Internet ISSN: 1938-3673 (Electronic) Linking ISSN: 07415400 NLM ISO Abbreviation: J Leukoc Biol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/pathology , Hematologic Neoplasms*, Humans ; T-Lymphocyte Subsets/metabolism ; Immunotherapy ; Receptors, Antigen, T-Cell ; Tumor Microenvironment

المؤلفون: Turner JA; Department of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.; Medical Scientist Training Program, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Fredrickson MA; Department of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., D'Antonio M; Department of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Katsnelson E; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., MacBeth M; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Van Gulick R; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Chimed TS; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., McCarter M; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., D'Alessandro A; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Robinson WA; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Couts KL; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Pelanda R; Department of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Klarquist J; Department of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Tobin RP; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA., Torres RM; Department of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA. raul.torres@cuanschutz.edu.

المصدر: Nature communications [Nat Commun] 2023 Jun 03; Vol. 14 (1), pp. 3214. Date of Electronic Publication: 2023 Jun 03.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Lysophospholipids*/metabolism , CD8-Positive T-Lymphocytes*, Monitoring, Immunologic ; Signal Transduction ; Receptors, Lysophosphatidic Acid/genetics ; Receptors, Lysophosphatidic Acid/metabolism

المؤلفون: Tobin RP; Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Cogswell DT; Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Cates VM; Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Davis DM; Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Borgers JSW; Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Van Gulick RJ; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Katsnelson E; Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Couts KL; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Jordan KR; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Gao D; Department of Pediatrics, Biostatistics, and Informatics, Cancer Center Biostatistics Core, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Davila E; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Medina TM; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Lewis KD; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Gonzalez R; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., McFarland RW; UCHealth Cancer Care and Hematology Clinic-Harmony Campus, Fort Collins, Colorado., Robinson WA; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., McCarter MD; Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 03; Vol. 29 (7), pp. 1209-1219.

نوع المنشور: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Myeloid-Derived Suppressor Cells*/pathology , Melanoma*/pathology , Neoplasms, Second Primary*/drug therapy, Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Tretinoin/adverse effects

المؤلفون: Newell F; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Johansson PA; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Nones K; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Lakis V; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Pritchard AL; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Department of Genetics and Immunology, Division of Biomedical Science, University of the Highlands and Islands, Inverness, Scotland, United Kingdom., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Kazakoff SH; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Koufariotis LT; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Wood S; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Leonard C; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Law MH; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia., Brooks KM; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Broit N; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Q-Gen Cell Therapeutics, Brisbane, Queensland, Australia., Palmer JM; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Couts KL; Center for Rare Melanomas, University of Colorado Cancer Center, Aurora, Colorado., Vergara IA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Royal North Shore Hospital, St Leonards, New South Wales, Australia., Barbour AP; Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Shivalingam B; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Department of Neurosurgery, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.; Department of Neurosurgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Robinson WA; Center for Rare Melanomas, University of Colorado Cancer Center, Aurora, Colorado., Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Royal North Shore Hospital, St Leonards, New South Wales, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, North Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Mann GJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia., Pearson JV; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Waddell N; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Hayward NK; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

المصدر: Cancer discovery [Cancer Discov] 2022 Dec 02; Vol. 12 (12), pp. 2856-2879.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/pathology , Skin Neoplasms*/genetics , Skin Neoplasms*/metabolism, Humans ; Ultraviolet Rays ; Genomics ; Mutation ; Melanoma, Cutaneous Malignant

SCR Disease Name: Uveal melanoma

المؤلفون: Akturk HK; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora.; Department of Pediatrics, University of Colorado School of Medicine, Aurora.; Department of Medicine, University of Colorado School of Medicine, Aurora., Couts KL; Department of Medicine, University of Colorado School of Medicine, Aurora.; University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora., Baschal EE; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora., Karakus KE; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora., Van Gulick RJ; Department of Medicine, University of Colorado School of Medicine, Aurora., Turner JA; Department of Medicine, University of Colorado School of Medicine, Aurora., Pyle L; Department of Pediatrics, University of Colorado School of Medicine, Aurora.; Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora., Robinson WA; Department of Medicine, University of Colorado School of Medicine, Aurora.; University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora., Michels AW; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora.; Department of Pediatrics, University of Colorado School of Medicine, Aurora.; Department of Medicine, University of Colorado School of Medicine, Aurora.; Department of Immunology, University of Colorado School of Medicine, Aurora.

المصدر: JAMA network open [JAMA Netw Open] 2022 Dec 01; Vol. 5 (12), pp. e2246400. Date of Electronic Publication: 2022 Dec 01.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological*/adverse effects , HLA-DR Antigens*/genetics , Immune Checkpoint Inhibitors*/adverse effects , Melanoma*/drug therapy , Melanoma*/genetics, Female ; Humans ; Male ; Middle Aged ; Alleles ; Case-Control Studies ; Melanoma, Cutaneous Malignant

المؤلفون: Mukherjee N; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Dart CR; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Amato CM; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Honig-Frand A; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Lambert JR; Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Lambert KA; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Robinson WA; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Tobin RP; Division of Surgical Oncology, Department of Surgery, School of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA., McCarter MD; Division of Surgical Oncology, Department of Surgery, School of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA., Couts KL; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Fujita M; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Dermatology Section, U.S. Department of Veterans Affairs Medical Center, Denver, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Norris DA; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Dermatology Section, U.S. Department of Veterans Affairs Medical Center, Denver, Colorado, USA., Shellman YG; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: Yiqun.Shellman@cuanschutz.edu.

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2022 Jul; Vol. 142 (7), pp. 1912-1922.e7. Date of Electronic Publication: 2021 Dec 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Melanoma*/drug therapy , Melanoma*/genetics , Skin Neoplasms*/drug therapy , Skin Neoplasms*/genetics, Animals ; Humans ; Mice ; Proto-Oncogene Proteins c-bcl-2 ; Uveal Neoplasms ; Melanoma, Cutaneous Malignant

SCR Disease Name: Uveal melanoma

المؤلفون: Turner JA; Division of Medical Oncology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA.; Medical Scientist Training Program, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA.; Department of Immunology and Microbiology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Paton EL; Division of Medical Oncology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Van Gulick R; Division of Medical Oncology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Stefanoni D; Department of Biochemistry and Molecular Genetics, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Cendali F; Department of Biochemistry and Molecular Genetics, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Reisz J; Department of Biochemistry and Molecular Genetics, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Tobin RP; Divion of Surgical Oncology, Department of Surgery, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., McCarter M; Divion of Surgical Oncology, Department of Surgery, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., D'Alessandro A; Department of Biochemistry and Molecular Genetics, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Torres RM; Department of Immunology and Microbiology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Robinson WA; Division of Medical Oncology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Couts KL; Division of Medical Oncology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA., Schlaepfer IR; Division of Medical Oncology, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA.

المصدر: Cancers [Cancers (Basel)] 2022 Apr 23; Vol. 14 (9). Date of Electronic Publication: 2022 Apr 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Vorwald VM; Division of Surgical Oncology Department of Surgery University of Colorado Anschutz Medical Campus Aurora CO USA., Davis DM; Division of Surgical Oncology Department of Surgery University of Colorado Anschutz Medical Campus Aurora CO USA., Van Gulick RJ; Division of Medical Oncology Department of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA., Torphy RJ; Division of Surgical Oncology Department of Surgery University of Colorado Anschutz Medical Campus Aurora CO USA., Borgers JS; Division of Surgical Oncology Department of Surgery University of Colorado Anschutz Medical Campus Aurora CO USA.; The Netherlands Cancer Institute Amsterdam The Netherlands., Klarquist J; Department of Immunology and Microbiology University of Colorado Anschutz Medical Campus Aurora CO USA., Couts KL; Division of Medical Oncology Department of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA., Amato CM; Division of Medical Oncology Department of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA., Cogswell DT; Division of Surgical Oncology Department of Surgery University of Colorado Anschutz Medical Campus Aurora CO USA., Fujita M; Department of Immunology and Microbiology University of Colorado Anschutz Medical Campus Aurora CO USA.; Department of Dermatology University of Colorado Anschutz Medical Campus Aurora CO USA., Castleman MJ; Department of Immunology and Microbiology University of Colorado Anschutz Medical Campus Aurora CO USA., Davis T; Department of Biochemistry and Molecular Genetics School of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA., Lozupone C; Division of Biomedical Informatics and Personalized Medicine Department of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA., Medina TM; Division of Medical Oncology Department of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA., Robinson WA; Division of Medical Oncology Department of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA., Gapin L; Department of Immunology and Microbiology University of Colorado Anschutz Medical Campus Aurora CO USA., McCarter MD; Division of Surgical Oncology Department of Surgery University of Colorado Anschutz Medical Campus Aurora CO USA., Tobin RP; Division of Surgical Oncology Department of Surgery University of Colorado Anschutz Medical Campus Aurora CO USA.

المصدر: Clinical & translational immunology [Clin Transl Immunology] 2022 Jan 10; Vol. 11 (1), pp. e1367. Date of Electronic Publication: 2022 Jan 10 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE